scispace - formally typeset
R

Roger A. Nicoll

Researcher at University of California, San Francisco

Publications -  401
Citations -  88229

Roger A. Nicoll is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: AMPA receptor & Long-term potentiation. The author has an hindex of 165, co-authored 397 publications receiving 84121 citations. Previous affiliations of Roger A. Nicoll include Genentech & Salk Institute for Biological Studies.

Papers
More filters
Journal ArticleDOI

Long-Term Potentiation--A Decade of Progress?

TL;DR: A simple model is described that unifies much of the data that previously were viewed as contradictory about the molecular mechanisms of this long-lasting increase in synaptic strength in the hippocampus.
Journal ArticleDOI

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.

TL;DR: The transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons is mediated by retrograde signalling through release of endogenous cannabinoids, indicating that the function of endogenous cannabinoid released by depolarized hippocampal neurons might be to downregulate GABA release.
Journal ArticleDOI

Evidence for silent synapses: Implications for the expression of LTP

TL;DR: It is demonstrated that it is possible to stimulate synapses that yield no detectable excitatory postsynaptic currents (EPSCs) when the cell is held at -60 mV; yet at positive holding potentials, EPSCs can be elicited that are completely blocked by the NMDAR antagonist, D-APV.
Journal ArticleDOI

PSD-95 Involvement in Maturation of Excitatory Synapses

TL;DR: It is found that overexpression of PSD-95 in hippocampal neurons can drive maturation of glutamatergic synapses and this results demonstrate that PSd-95 can orchestrate synaptic development and are suggestive of roles for PSD -95 in synapse stabilization and plasticity.
Journal ArticleDOI

Endocannabinoid signaling in the brain.

TL;DR: The primary psychoactive ingredient in cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), affects the brain mainly by activating a specific receptor (CB1) and suppressing neurotransmitter release.